Dr Darrin M Disley Obe

BitBio is an online science community and resource built by researchers and service providers in the life science industries. Gain instant access to new resources, providers, and equipment you may have otherwise not found, and exchange science research projects or services with hospitals, universities, research institutes, or other service providers across the globe. Find out what scientific methods other researchers or service providers are using. Search for projects to exchange science advice, opinions, and services. Learn about new research, methods, and technologies to use for your project and what the science market has to offer. Quickly promote research questions and answers in the science community to help a fellow colleague. Why rely on expensive services to broker your science project when all you really need is access, exposure, and some help from the science community.

At Axol Bioscience, we support your pursuit of more effective, safer therapies. Like you, we believe that having more human-relevant disease models will expand scientific knowledge and de-risk drug development. We use human iPSCs to achieve this and have been doing so since 2006. We use donated cells from patients and iPSC technology to build physiologically relevant in vitro models. We have a special focus on neurodegenerative diseases like Alzheimer’s disease as well as cardiotoxicity to promote drug safety. When working with candidate compounds or novel therapies, our in vitro platforms give you better earlier-stage modeling and safety testing and later-stage efficacy evaluation and improved patient selection. With these data comes better insights, helping you de-risk projects, reduce costs, and save time during drug development.

Roquefort Therapeutics is a LSE Main Market listed biotech company developing first in class drugs in the high value and high growth oncology segment prior to partnering or selling to big pharma. Since listing in March 2021, Roquefort Therapeutics has successfully acquired Lyramid Pty Limited, a leader in the development of medicines for a new therapeutic target, Midkine (a human growth factor associated with cancer progression), and most recently acquired Oncogeni Ltd, founded by Nobel Laureate Professor Sir Martin Evans, which has developed two families of innovative cell and RNA oncology medicines. Roquefort Therapeutics’ portfolio consists of four fully funded, novel patent-protected pre-clinical anti-cancer medicines. The highly complementary profile of four best-in-class medicines consists of: 1. Midkine antibodies with significant in vivo efficacy and toxicology studies; 2. Midkine RNA therapeutics with novel anti-cancer gene editing action; 3. MK cell therapy with direct and NK-mediated anti-cancer action; and 4. siRNA targeting novel STAT-6 target in solid tumours showing significant in vivo efficacy.

TechBio businesses are using data to transform healthcare and promote a more sustainable future. At Sana Capital, we are pioneering support in today’s TechBio ventures to build businesses that will shape our world tomorrow. We support TechBio ventures: data-driven life-science companies working at the interface of bio and tech that… …combine cutting-edge techniques from both sectors …develop IP …use data concerning patients, drug molecules, healthcare infrastructure or R&D …aim to deliver more personalised healthcare to more patients, more quickly and cost-efficiently, or …tackle issues relating to food, clean air, water or shelter impacting our health.

BitBio is an online science community and resource built by researchers and service providers in the life science industries. Gain instant access to new resources, providers, and equipment you may have otherwise not found, and exchange science research projects or services with hospitals, universities, research institutes, or other service providers across the globe. Find out what scientific methods other researchers or service providers are using. Search for projects to exchange science advice, opinions, and services. Learn about new research, methods, and technologies to use for your project and what the science market has to offer. Quickly promote research questions and answers in the science community to help a fellow colleague. Why rely on expensive services to broker your science project when all you really need is access, exposure, and some help from the science community.